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Abstract
Background
There are widely recognised variations in the delivery and outcomes of healthcare but an
incomplete understanding of their causes. There is a growing interest in using routinely col-
lected ‘big data’ in the evaluation of healthcare. We developed a set of evidence-based ‘high
impact’ quality indicators (QIs) for primary care and examined variations in achievement of
these indicators using routinely collected data in the United Kingdom (UK).
Methods
Cross-sectional analysis of routinely collected, electronic primary care data from a sample
of general practices in West Yorkshire, UK (n = 89). The QIs covered aspects of care
(including processes and intermediate clinical outcomes) in relation to diabetes, hyperten-
sion, atrial fibrillation, myocardial infarction, chronic kidney disease (CKD) and ‘risky’ pre-
scribing combinations. Regression models explored the impact of practice and patient
characteristics. Clustering within practice was accounted for by including a random intercept
for practice.
Results
Median practice achievement of the QIs ranged from 43.2% (diabetes control) to 72.2%
(blood pressure control in CKD). Considerable between-practice variation existed for all indi-
cators: the difference between the highest and lowest performing practices was 26.3 per-
centage points for risky prescribing and 100 percentage points for anticoagulation in atrial
fibrillation. Odds ratios associated with the random effects for practices emphasised this;
there was a greater than ten-fold difference in the likelihood of achieving the hypertension
indicator between the lowest and highest performing practices. Patient characteristics, in
particular age, gender and comorbidity, were consistently but modestly associated with
PLOS ONE | https://doi.org/10.1371/journal.pone.0177949 July 13, 2017 1 / 18
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Willis TA, West R, Rushforth B, Stokes T,
Glidewell L, Carder P, et al. (2017) Variations in
achievement of evidence-based, high-impact
quality indicators in general practice: An
observational study. PLoS ONE 12(7): e0177949.
https://doi.org/10.1371/journal.pone.0177949
Editor: Monika R. Asnani, University of the West
Indies Faculty of Medical Sciences Mona, JAMAICA
Received: September 6, 2016
Accepted: May 5, 2017
Published: July 13, 2017
Copyright: © 2017 Willis et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The data collected
are not available to be publicly shared. While data
was anonymised, unique combinations of patient
characteristics could identify individuals. At the
point of recruitment to the study, we did not obtain
permission from participating practices to make
potentially sensitive performance data available
publicly. The ethics application, which was
submitted to and approved by an NHS Research
Ethics Committee, assures that no individual
patients or practices will be identifiable from the
analyses. There is no indication within this form or
indicator achievement. Statistically significant practice characteristics were identified less
frequently in adjusted models.
Conclusions
Despite various policy and improvement initiatives, there are enduring inappropriate varia-
tions in the delivery of evidence-based care. Much of this variation is not explained by rou-
tinely collected patient or practice variables, and is likely to be attributable to differences in
clinical and organisational behaviour.
Introduction
Clinical and health services research continually produces new evidence that can benefit
patients. However, this evidence does not reliably find its way into everyday patient care [1].
This gap between evidence and clinical practice is a strategically important problem for policy-
makers, healthcare systems and research funders because it limits the health, social and eco-
nomic impacts of research [2].
There are particular implementation challenges specific to primary care that are not
encountered in other settings. These include rising workloads and demands upon practice:
Hobbs et al. have shown substantial increases in both the number and duration of practice
consultations in UK primary care over the period 2007–14 [3]. This needs to be considered
alongside the complex management of escalating numbers of ageing and multimorbid patients
[4], and rising public expectations [5], all in the context of limited practice organisational
capacity and continual reforms of general practices [6, 7].
These system strains are compounded by multiple, often competing implementation priori-
ties. In 2012, we identified 107 National Institute for Health and Care Excellence (NICE) clini-
cal guidelines relevant to primary care, as well as 114 specific quality indicators. Together,
these yielded a total of 2365 clinical practice recommendations [8]. Several recent studies have
identified the problems that may arise when attempting to apply guidelines to patients with
multiple morbidities [e.g. 9, 10, 11]. These contextual factors go some way towards explaining
the well-documented variations in the delivery of primary care that are consistently observed
in the United Kingdom (UK) and internationally [12, 13]. In England, there is evidence that
the overall standard of care is improving [14, 15] but the variation between general practices
remains [e.g. 16, 17, 18].
‘Big data’ offers considerable promise in healthcare research [19, 20]. One potential oppor-
tunity is in the measurement of quality of care delivered across populations. A prime example
is the NHS Atlas of Variation in Healthcare [21], which illustrates large geographical variations
across England in the level and quality of care in several clinical areas, including diabetes,
stroke and cancer. The magnitude of these differences cannot be easily explained by popula-
tion and casemix factors. Indeed, the Foreword to the Atlas notes that the variation caused by
“the idiosyncratic practices of clinicians and of healthcare organisations” represents unwar-
ranted variation (p.15). Variation per se is not necessarily inappropriate; however, the varia-
tion examined here is considered ‘inappropriate’ as it means that many patients are generally
not receiving recommended care. This is distinct from variation in care where there is not a
recommended standard.
Enhanced delivery of care can have substantial implications. For example, it has been esti-
mated that in England more than 7000 strokes per year could be prevented, and 2100 lives
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saved, with increased adherence to guidelines on the management of atrial fibrillation and use
of recommended therapy [22].
Clearly, quality improvement initiatives cannot focus on all clinical practice recommenda-
tions at once; there is a need to identify and prioritise those with the potential for the most pos-
itive impact for patients. In earlier work [8], we identified a set of evidence-based quality
indicators (QIs) based on criteria including: burden of illness (e.g. prevalence, severity); poten-
tial for significant patient benefit (e.g. longevity, quality of life); scope for improvement upon
current levels of achievement; the extent to which following a recommendation is directly
within the control of individual practice teams; and the feasibility of measurement using rou-
tinely collected data. This work yielded a set of QIs that we termed ‘high impact’.
We examined achievement against a set of these QIs in a sample of practices in a region of
the UK. We aimed to examine the extent to which variations in achievement to high impact
indicators can be explained using routinely collected data.
Methods
Study design and setting
We conducted a cross-sectional analysis of achievement against selected clinical quality indica-
tors (QIs) using routinely collected, electronic primary care data from a sample of general
practices in West Yorkshire, UK. Our analysis included patient and practice characteristics to
explore associations with indicator achievement. Data covered the period 1 January 2012 to 31
March 2013, and were extracted during April 2014. The demographic characteristics of the
334 general practices in West Yorkshire are broadly typical of the average across England, with
the exception of higher levels of deprivation (practice averaged Index of Multiple Deprivation
(IMD) score 29.0 vs 21.8).
Participants
Of the 334 general practices in West Yorkshire at the time of the study, 272 used the SystmOne
clinical information system (TPP, http://www.tpp-uk.com/). This system permits centralised
data collection. We sampled randomly from this group and stratified according to the then
configured five NHS Primary Care Trusts (PCTs). Assuming a 30% decline rate, we initially
approached 78 practices using a conventional, ‘opt in’ approach. After receiving some declines
and a small number of acceptances, we decided to approach more practices in order to ensure
that our target was reached. We therefore sampled an additional 36 practices, making 114 in
total. At the same time, we were granted permission to change to ‘opt out’ recruitment to
reduce selection bias by facilitating general practices’ agreement to share anonymised patient
data. Ninety three practices did not respond to the initial invitation and were sent a second let-
ter that explained that they could opt out if they did not wish to share data.
Variables
All clinical data were routinely recorded by practices and amenable to remote extraction.
Many of the variables were linked to conditions included in the UK Quality and Outcomes
Framework (QOF) year 2012/13. QOF is a pay-for-performance scheme whereby general
practices are remunerated according to achievement of targets reflecting the quality of care
delivered by the practice [23]. Practice data collection for QOF operates on an annual cyclical
basis from 1 April to 31 March. QOF has driven consistent electronic recording of data in gen-
eral practice and practices routinely record data for incentivised conditions on investigations,
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prescriptions and intermediate outcomes, such as blood pressure, or glycated haemoglobin
[24].
Our dependent variables were drawn from a set of eighteen ‘high impact’ QIs developed by
an earlier, multidisciplinary consensus process [8]. The list was reduced to seven indicators
(Table 1) following initial data collection and analysis. The level of scope for improvement and
Table 1. Details of the clinical indicators included in the study.
Indicator Description
Process indicators
1. Diabetes: processes of care A composite indicator recording the proportion of eligible patients
that received all of nine recommended processes of care: blood
pressure (BP) measurement, glycated haemoglobin (HbA1c)
measurement, cholesterol measurement, urine albumin:
creatinine ratio (ACR) / protein:creatinine (PCR) testing or
proteinuria code, estimated Glomerular Filtration Rate (eGFR) or
serum creatinine testing, foot review, retinal screening, body
mass index (BMI) recording, smoking status, within the last 15
months (six months for HbA1c measurement).
2. Risky prescribing A set of nine indicators largely focusing on avoiding adverse
gastrointestinal, renal and cardiac effects of non-steroidal anti-
inflammatory drugs (NSAIDs) and anti-platelet drugs: prescribing
a traditional oral NSAID or low-dose aspirin in patients with a
history of peptic ulceration without co-prescription of gastro-
protection; prescribing a traditional oral NSAID in patients aged
75 years or over without co-prescription of gastro-protection;
prescribing of a traditional oral NSAID and aspirin in patients
aged 65 years or over without co-prescription of gastro-
protection; prescribing of aspirin and clopidogrel in patients aged
65 years or over without co-prescription of gastro-protection;
prescribing of warfarin and a traditional oral NSAID without co-
prescription of gastro-protection; prescribing of warfarin and low-
dose aspirin or clopidogrel without co-prescription of gastro-
protection; prescribing an oral NSAID in patients with heart
failure; prescribing an oral NSAID in patients prescribed both a
diuretic and an angiotensin-converting-enzyme inhibitor (ACE
inhibitor) or angiotensin receptor blocker (ARB); and prescribing
an oral NSAID in patients with chronic kidney disease (CKD)
3. Anticoagulation in atrial fibrillation
(AF) and risk of stroke
A single indicator examining recommended treatment of patients
with AF and at greater risk of stroke. The proportion of patients
with a record of AF and a score of two or higher on the CHADS2
risk tool who have a current prescription for anti-coagulation
therapy.
4. Secondary prevention of
myocardial infarction (MI)
A single indicator showing the proportion of patients with a
lifetime record of MI who are receiving the recommended four
drugs: ACE inhibitor or ARB, aspirin or antiplatelet, beta-blocker,
and statin.
Outcome indicators
5. Diabetes control A composite indicator recording the proportion of patients with
Type 2 diabetes that achieve each of three recommended target
levels: BP <140/80 mmHg (or <130/80 mmHg if kidney, eye or
cerebrovascular damage), HbA1c59 mmol/mol, and
cholesterol 5 mmol/l.
6. Blood pressure control in
hypertension
A combination of two indicators recording the proportion of
patients achieving individual, age-dependent targets in the
previous nine months: BP <140/90 mmHg if aged under 80 years,
or <150/90 mmHg if aged 80 years or more.
7. Blood pressure control in chronic
kidney disease (CKD)
A combination of two indicators assessing the achievement of
recommended BP targets in specific patient groups: <140/85
mmHg, or <130/80 mmHg if record of diabetes or proteinuria.
https://doi.org/10.1371/journal.pone.0177949.t001
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potential for intervention were of primary importance in the selection process. Other indica-
tors were rejected due to concerns about the reliability of routinely collected data or uncer-
tainty about the ongoing use of the clinical indicator.
Four indicators focused on processes of care (e.g. prescribing or testing) and three on clini-
cal outcomes (the achievement of recommended targets for the intermediate health outcomes
of blood pressure, cholesterol and glycaemic control). Several indicator sets consisted of multi-
ple individual recommendations that were then pooled to permit analysis of achievement.
Two of these were composites, assessing the degree to which all recommended care processes
or treatment targets were achieved for individual patients (e.g. blood pressure, cholesterol and
glycaemic values within recommended ranges for patients with Type 2 diabetes [indicator 5:
diabetes control]). Others were formed from combinations of individual recommendations,
but could not be considered composites in the truest sense as they did not necessarily all apply
to a single individual. For example, the risky prescribing indicator (indicator 2) combined
nine individual instances of prescribing that might be considered high-risk; six concerned gas-
tro-intestinal risks, two renal risks and one heart failure. These have been detailed elsewhere
[25, 26]. Individual patients may have been exposed to one or more of the prescribing risks
and the combined measure gave an overall signal of practice risky prescribing. This latter indi-
cator was scored in the opposing direction to the others: lower values here generally suggest
safer, more desirable practice, while higher values were desirable on all other indicators. When
producing combined indicators, all indicators were equally weighted on the basis that they had
all been through a priority-setting process [8] and were considered clinically important.
Independent variables included patient- and practice-level characteristics we hypothesised
or recognised from earlier work to be associated with practice performance [27, 28]. At the
patient level we examined demographic (age, gender and ethnicity), and illness variables. Ill-
ness was assessed by a measure of comorbidity: the number of QOF disease registers on which
a patient appeared.
Practice-level variables comprised the number of practice partners (which served as a proxy
of practice size), the number of salaried family physicians, and training status—all recorded as
at April 2014. We used practice-level Index of Multiple Deprivation (IMD) scores. This mea-
sures area deprivation and is determined for each patient on the list, where available, and then
averaged over the practice. Overall achievement in the QOF clinical domain (2012–13) was
used as a proxy measure for overall quality of care. By providing a wide-ranging and objective
measure of items recommended by professionals and patients, it is generally accepted that the
QOF offers a good snapshot of quality [29]. Practice prescribing costs over the period were
also collected, measured as cost per Age, Sex and Temporary Resident Prescribing Unit
(ASTRO-PU) over the year 2012–13.
Two further practice-level variables were included: patient satisfaction (the proportion
reporting that they would recommend the practice to others) and practice accessibility (the
proportion reporting that they were able to speak with a family physician/nurse within 48
hours of approach).
Data sources
The NHS Yorkshire and Humber Commissioning Support Unit remotely extracted data from
participating practices. The Unit also supplied information on general practice characteristics
and practice prescribing data. Patient data were anonymised before transfer to the research
team.
Patient satisfaction and practice accessibility data were obtained from the publicly available
National General Practice Profiles [30].
Variations in achievement of indicators in general practice
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Analysis
We examined sample representativeness by comparing characteristics of participating versus
non-participating general practices using the Wilcoxon rank sum test with Monte Carlo per-
mutation sampling. This analysis has been presented elsewhere [31].
Descriptive statistics for the practice and patient variables are presented via means and stan-
dard deviations, or median and inter-quartile range where distributions were skewed.
For each clinical indicator we assessed the proportion of cases with documented receipt of
appropriate care or target value, as required. Denominators were eligible patients (identified
by diagnostic codes and other markers, e.g. prescribing of indicated drugs). Numerators were
patients with evidence of a clinical intervention offered or received, or meeting defined treat-
ment targets.
In assessing the impact of practice and patient characteristics, we initially calculated unad-
justed odds ratios (ORs) and then adjusted for other variables associated with outcome. We
took a parsimonious approach to model selection, retaining significant terms. We added addi-
tional variables in a stepwise fashion, with guidance from classification tree and random forest
results. We treated ethnicity as a random effects variable to accommodate the large number of
categories of ethnicity.
The categories within covariates were formed on a pragmatic basis. Patient age was typi-
cally handled as quartiles: <40 years, 40–59 years, 60–79 years, and 80+ years. Other catego-
ries were dichotomised using median split (e.g. practice QOF performance, practice
accessibility) or approximations of this to provide two meaningful groups (e.g. proportion
of salaried family physicians was categorised as 0–25%, 26–100%). Precise categories some-
times differed between indicators because the number of patients varied according to the
specific patient group under consideration (e.g. the median value for QOF performance was
645 for diabetes outcomes (~25,000 patients) and 650 for blood pressure control (~78,000
patients)).
It is important to acknowledge that patients are clustered within practices and that practices
have an influence over indicator achievement. Logistic regression was used to model achieve-
ment with both patient-level and practice-level variables. To account for practice influences
beyond the practice-level variables, a random intercept term was added to the logistic regres-
sion. The range of odds ratios due to the random intercept was calculated and reported so that
the influence of practices expressed by the random intercept can be compared to the associa-
tions with other (fixed) variables. Further detail was given by reporting the variance of the
practice random intercept as well as the intra-class correlation coefficient (ICC). The ICC can
be regarded as providing the proportion of variability due to the general practice.
It is acknowledged that patient assignment to individual practices is likely imperfect and
contains measurement error. Practice assignment was taken at the time of extraction and it is
therefore assumed that patients were receiving care from that practice throughout the period
of interest, but this may not necessarily be so.
Data for almost all patients were complete. Data on age were missing from a small propor-
tion (<1%) of patients and these were excluded from the analysis.
Study size
Effect size calculations informed a recruitment target of 60 practices. With seven covariates,
and a large effect size (defined by a difference of at least 0.8 standard deviations[32]), 60 prac-
tices would provide 94% power.
Variations in achievement of indicators in general practice
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Ethical approval
The study, including use of opt out recruitment and anonymised, patient-level data, was
approved by the NHS Leeds Central Research Ethics Committee (12/YH/0254).
Results
Participants
Eighty nine practices (78.1% of those approached) shared patient data. Of the 114 practices
originally approached, 22 opted out of data sharing: one had closed, one had merged and it
transpired that another provided care for an atypical population. Practices which declined par-
ticipation only differed from participating practices in having a smaller mean number of fam-
ily physicians (5 vs. 3.6; p = 0.05). The total number of patients in the denominator for each
indicator ranged from 4,773 (anticoagulation in atrial fibrillation and risk of stroke) to 77,587
(blood pressure control in hypertension). Patient demography is summarised in Table 2. Prac-
tice size was indicated by the number of practice partners (mean [M] 3.7, standard deviation
[sd] 2.3) and salaried family physicians (M = 1.3, sd = 1.8). Mean practice-aggregated Index of
Multiple Deprivation score was 31.2 (sd = 11.9). Mean QOF 2012/13 performance across prac-
tices was 637.4 (sd = 27.6) and 20.2% of the sample were registered as training practices. Mean
practice prescribing costs (total Net Ingredient Cost per 1000 ASTRO-PUs [Age, Sex and Tem-
porary Resident Prescribing Unit] were £50.4 (sd = 9.5). Patient reported satisfaction
(M = 76.5%, sd = 13.4) and practice accessibility (M = 53.5%, sd = 14.4) were obtained.
Achievement of indicators
Median practice achievement of the indicators under consideration ranged from 43.2% (diabe-
tes outcomes) to 74.2% (blood pressure control in chronic kidney disease (CKD)) (Tables 3
and 4). Median achievement of the risky prescribing indicator was 8.7%, but this was scored
such that a low score was indicative of fewer instances of risky prescribing and was therefore
desirable. Considerable between-practice variation in achievement existed on all indicators:
the difference between the highest and lowest achievers was 26.3 percentage points for risky
prescribing and 100 percentage points for anticoagulation in atrial fibrillation. The variation
in achievement of the indicator examining blood pressure in hypertension is presented as an
example (Fig 1).
Associations with achievement
The range of odds ratios associated with the random effects for practices demonstrate that the
likelihood of achieving a specific indicator varied substantially as a consequence of the practice
attended (Tables 3 and 4). These ORs were typically of a much greater magnitude than those
for other variables, demonstrating strong practice effects. For process indicators, the impact of
the practice attended was most pronounced for risky prescribing: a seven-fold difference
between the lowest and highest performing practices (OR range 0.40 to 3.51), after adjusting for
the variables included in our model. Practice effects were least apparent for secondary preven-
tion of MI (OR range 0.70 to 1.42). There were also sizeable practice effects for outcome indica-
tors. For the achievement of target blood pressure values in hypertension there was a greater
than ten-fold difference between the highest and lowest performing practices (OR range 0.50 to
5.24) and for diabetes control the difference was approximately four-fold (OR range 0.51 to
2.05). Practice effects were less marked for the achievement of blood pressure targets in CKD
(OR range 0.54 to 1.60). Across the seven indicators, statistically significant associations were
identified more frequently with patient than practice characteristics (Tables 3 and 4). The
Variations in achievement of indicators in general practice
PLOS ONE | https://doi.org/10.1371/journal.pone.0177949 July 13, 2017 7 / 18
amount of variance explained by these variables, however, was relatively low; practice character-
istics explained less than 8% of variance across all seven models. Variance due to patient ethnic-
ity typically explained a small amount of the variance in achievement (less than 10% of the
variation due to practice).
Process indicators. Diabetes processes of care. Males were more likely to receive all nine of
the recommended processes of care in diabetes, compared to females (adjusted OR 1.24, 95%
confidence interval [CI] 1.17 to 1.30). Relative to younger patients, receipt was more likely in
each of the age groups above 40 years old: 40–59 years (1.52, 1.33 to 1.73), 60–79 years (2.07,
1.81 to 2.36) and 80 years and over (1.51, 1.30 to 1.76). Indicator achievement was more likely
in those with a greater number of comorbidities: compared with patients appearing on 0–3
QOF registers, the odds were higher for those on 4–5 registers (1.24, 1.17 to 1.32) and 6–13
registers (1.33, 1.23 to 1.45).
Risky prescribing. The odds of receiving at least one of the included risky prescribing combi-
nations were greater in males (1.11, 1.02 to 1.19) than females. Risky prescribing was more
likely in patients aged 40–59 years (1.71, 1.12 to 2.60) and 60–79 years (1.95, 1.26 to 2.96), but
not in those aged 80 years and above, relative to patients under 40 years. Compared with
patients with 0–3 comorbidities, risky prescribing was less likely in those on 4–5 (0.81, 0.74 to
0.88) and 6–11 (0.56, 0.51 to 0.62) QOF registers. Attending a practice with a greater propor-
tion of salaried family physicians was also associated with lower occurrence of risky prescrib-
ing (0.76, 0.61 to 0.94).
Anticoagulation in atrial fibrillation and risk of stroke. Males (1.27, 1.12 to 1.44) were more
likely than females to receive the recommended anticoagulation. Patients aged 80 years and
older were less likely to do so (0.62, 0.43 to 0.89) than those aged under 60 years.
Secondary prevention of myocardial infarction. Males were more likely than females to
receive the recommended four medications as secondary prevention of MI (1.12, 1.02 to 1.23).
Patients aged 80 years and older were less likely to do so (0.38, 0.22 to 0.65) than those in the
youngest quartile. Relative to patients on 0–3 QOF registers, the odds were reduced in patients
with higher levels of comorbidity, as indicated by featuring on six or more QOF registers
(0.83, 0.73 to 0.94).
Outcome indicators. Diabetes control. The odds of achieving all three target values in dia-
betes (BP, cholesterol and HbA1c) were slightly higher in males (1.09, 1.03 to 1.14) than
females. The likelihood also increased with age, with all three age groups significantly more
likely than patients aged under 40 years to achieve the recommendation (40–59 years: 1.28,
1.10 to 1.47; 60–79 years: 2.55, 2.21 to 2.94; 80 years and above: 2.91, 2.48 to 3.40). A greater
level of comorbidity was also associated with indicator achievement: patients on 4–5 QOF reg-
isters (1.10, 1.04 to 1.17) and 6–13 QOF registers (1.31, 1.21 to 1.42) were more likely to
Table 2. Patient characteristics for cross-sectional analysis of associations with achievement on selected quality indicators.
Quality indicator
1 2 3 4 5 6 7
Number of patients 25 816 37 546 4 773 9 258 25 816 77 587 17 669
Mean age in years (sd) 64.2 (13.6) 71.4 (12.3) 78.96 (8.73) 69.8 (12.1) 64.2 (13.6) 66.7 (13.2) 75.1 (11.39)
Female gender 45.8% 55.8% 49.6% 30.5% 45.8% 52.8% 60.2%
Median number of comorbidities (IQR) 4 (3–5) 3 (2–5) 5 (4–6) 4 (3–5) 4 (3–5) 3 (2–4) 4 (3–5)
sd = standard deviation; IQR = Interquartile range
Quality indicators: 1 Diabetes processes of care, 2 Risky prescribing, 3 Anticoagulation in atrial fibrillation and risk of stroke, 4 Secondary prevention of
myocardial infarction, 5 Diabetes control, 6 Blood pressure control in hypertension, 7 Blood pressure control in chronic kidney disease
https://doi.org/10.1371/journal.pone.0177949.t002
Variations in achievement of indicators in general practice
PLOS ONE | https://doi.org/10.1371/journal.pone.0177949 July 13, 2017 8 / 18
Table 3. Practice and patient characteristics significantly associated with process indicators in cross-sectional analysis.
Diabetes processes of care1 Risky prescribing2 Anticoagulation in atrial
fibrillation and risk of stroke3
Secondary prevention of
myocardial infarction (MI)4
Number of patients in
analysis
25 816 37 546 4 773 9 258
Median achievement (%) 59.1 8.7 63.0 54.6%
Range of achievement (%) 8.8–82.3 1.4–27.7 0–100 25.0–83.3
Range of odds ratios (ORs)
for practice residuals
0.09–3.25 0.40–3.51 0.46–1.64 0.70–1.42
Practice intraclass
correlation coefficient (ICC)
0.077 0.056 0.03 0.011
Practice-level variance 0.276 0.194 0.103 0.036
Ethnicity variance 0.008 0.004 0.101 0.011
Patient variables Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Female 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Male 1.22 (1.16, 1.29) 1.24 (1.17,
1.30)
1.14 (1.06, 1.23) 1.11 (1.02,
1.19)
1.45 (1.28, 1.63) 1.27 (1.12,
1.44)
1.35 (1.24, 1.48) 1.12 (1.02,
1.23)
Age by tertile
13–59 years - - - - 1.0 1.0 - -
60–79 years - - - - 1.32 (0.93, 1.87) 1.29 (0.90,
1.86)
- -
80–107 years - - - - 0.61 (0.43, 0.87) 0.62 (0.43,
0.89)
- -
Age by quartile
13–39 years 1.0 1.0 1.0 1.0 1.0 1.0
40–59 years 1.58 (1.39, 1.80) 1.52 (1.33,
1.73)
1.53 (1.00, 2.34) 1.71 (1.12,
2.60)
1.25 (0.73, 2.13) 1.36 (0.79,
2.33)
60–79 years 2.26 (1.99, 2.56) 2.07 (1.81,
2.36)
1.60 (1.06, 2.43) 1.95 (1.29,
2.96)
0.68 (0.40, 1.16) 0.78 (0.45,
1.33)
80–107 years 1.71 (1.49, 1.96) 1.51 (1.30,
1.76)
0.86 (0.56), 1.31) 1.10 (0.72,
1.69)
- - 0.32 (0.19, 0.54) 0.38 (0.22,
0.65)
Number of comorbidities by
tertile
Lower third 1.0 1.0 1.0 1.0 - - 1.0 1.0
Middle third 1.34 (1.27, 1.41) 1.24 (1.17,
1.32)
0.81 (0.74, 0.88) 0.81 (0.74,
0.88)
- - 0.83 (0.76, 0.91) 1.00 (0.91,
1.11)
Upper third 1.49 (1.38, 1.60) 1.33 (1.23,
1.45)
0.55 (0.49, 0.60) 0.56 (0.51,
0.62)
- - 0.63 (0.56, 0.70) 0.83 (0.73,
0.94)
Practice variables
Proportion of salaried
physicians <0.25
- - 1.0 1.0 - - - -
Proportion of salaried
physicians 0.25
- - 0.73 (0.67, 0.78) 0.76 (0.61,
0.94)
- - - -
1 Diabetes processes of care. Comorbidity tertiles: 0–3, 4–5, 6–13.
2 Risky prescribing. Comorbidity tertiles: 0–2, 3–4, 5–13. Note: This indicator scored in the opposite direction, such that lower values generally suggest
safer, more desirable practice.
3 Anticoagulation in atrial fibrillation and risk of stroke. Data from n = 88 practices as one had no eligible patients.
4 Secondary prevention of myocardial infarction. Comorbidity tertiles: 2–3, 4–5, 6–11.
The following practice and patient variables were not significantly associated with achievement: patient-level ethnicity; and practice-level number of practice
partners, Index of Multiple Deprivation score (IMD), QOF performance 2012/13, practice training status, patient satisfaction, practice accessibility, and
practice prescribing costs.
https://doi.org/10.1371/journal.pone.0177949.t003
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achieve the targets than those on 0–3 registers. Practices with a better than average QOF per-
formance (1.19, 1.02 to 1.39) and those with better reported accessibility (1.18, 1.02 to 1.38)
were more likely to achieve this indicator.
Blood pressure control in hypertension. Achievement of target blood pressure values in
hypertension was more likely in females than males (0.86, 0.84 to 0.89). The likelihood also
increased with age, with patients aged 60–79 years (1.19, 1.07 to 1.31) and particularly those
aged 80 years or older (3.34, 2.99 to 3.74) more likely to achieve the indicator than patients
aged under 40 years. Compared to patients on 0–3 QOF registers, greater levels of comorbidity
were associated with indicator achievement (3–4 QOF registers: 1.54, 1.48 to 1.60; 5–13 regis-
ters: 2.32, 2.20 to 2.44). One practice variable was associated with this indicator: achievement
was more likely in practices with greater than average QOF performance (1.24, 1.06 to 1.46).
Table 4. Patient and practice characteristics significantly associated with outcome indicators in cross-sectional analysis.
Diabetes control1 Blood pressure control in
hypertension2
Blood pressure control in chronic
kidney disease3
Number of patients in analysis 25 816 77 587 17 669
Median achievement (%) 43.2 71.7 74.2
Range of achievement (%) 20.8–66.2 54.7–96.3 50.7–100
Range of odds ratios (ORs) for
practice residuals
0.51–2.05 0.50–5.24 0.54–1.60
Practice intraclass correlation
coefficient (ICC)
0.033 0.039 0.028
Practice-level variance 0.112 0.134 0.089
Ethnicity variance 0.0004 0.094 0.043
Patient variables Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Female 1.0 1.0 1.0 1.0 - -
Male 1.03 (0.98, 1.08) 1.09 (1.03, 1.14) 0.80 (0.78, 0.83) 0.86 (0.83, 0.89) - -
Age by quartile
13–39 years 1.0 1.0 1.0 1.0 - -
40–59 years 1.28 (1.11, 1.48) 1.28 (1.10, 1.47) 1.10 (1.00, 1.22) 1.07 (0.96, 1.18) - -
60–79 years 2.59 (2.25, 2.97) 2.55 (2.21, 2.94) 1.37 (1.24, 1.51) 1.22 (1.10, 1.35) - -
80–107 years 3.04 (2.62, 3.53) 2.91 (2.48, 3.40) 4.17 (3.74, 4.65) 3.45 (3.08, 3.86) - -
Number of comorbidities by tertile
Lower third 1.0 1.0 1.0 1.0 1.0 1.0
Middle third 1.30 (1.23, 1.37) 1.10 (1.04, 1.17) 1.72 (1.67, 1.79) 1.57 (1.51, 1.63) 0.89 (0.82, 0.96) 0.88 (0.81, 0.95)
Upper third 1.78 (1.66, 1.92) 1.31 (1.21, 1.42) 2.93 (2.79, 3.08) 2.41 (2.29, 2.54) 0.87 (0.80, 0.95) 0.86 (0.79, 0.95)
Practice variables
QOF performance median split
QOF performance lower 1.0 1.0 1.0 1.0 - -
QOF performance upper 1.17 (1.11, 1.22) 1.19 (1.02, 1.39) 1.15 (1.11, 1.19) 1.19 (1.02, 1.40) - -
Accessibility <54.7% 1.0 1.0 - - - -
Accessibility54.7% 1.12 (1.07, 1.18) 1.18 (1.02, 1.38) - - - -
1 Diabetes control. Comorbidity tertiles: 0–3, 4–5, 6–13; QOF performance median split: <645,645
2 Blood pressure control in hypertension. Comorbidity tertiles: 0–2, 3–4, 5–13; QOF performance median split: <650,650
3 Blood pressure control in chronic kidney disease. Comorbidity tertiles: 1–3, 4–5, 6–13.
The following practice and patient variables were not significantly associated with achievement: patient-level ethnicity; and practice-level number of practice
partners, proportion of salaried family physicians, practice training status, Index of Multiple Deprivation score (IMD), patient satisfaction, and practice
prescribing costs.
https://doi.org/10.1371/journal.pone.0177949.t004
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Blood pressure control in chronic kidney disease. The only patient or practice characteristic
associated with the achievement of target blood pressure in CKD was comorbidity. Target
achievement was less likely as the level of comorbidity increased, through 4–5 (OR = 0.88, 95%
CI = 0.81, 0.95) and 6–13 QOF registers (OR = 0.86, 95% CI = 0.79, 0.95), respectively.
Discussion
We found marked variations between general practices in the achievement of clinically impor-
tant quality indicators. The odds of patients receiving recommended care or achieving recom-
mended treatment targets varied between two- and over ten-fold by indicator according to the
practice attended. These marked variations were partly explained by a range of routinely avail-
able practice and patient variables; it is likely that much variation is related to clinical and orga-
nisational behaviours.
We have demonstrated inappropriate variations for a set of ‘high impact’, evidence-based
indicators judged important by clinicians and patients [8]. We did anticipate suboptimal per-
formance given that scope for improvement was an initial selection criterion for the indicators,
although we did not know the actual extent of variation. Our findings are generally consistent
with previous studies, in England [15, 17, 18] and worldwide [12, 13, 33]. Three of our indica-
tors (diabetes processes and control, anticoagulation in atrial fibrillation) show similar varia-
tions in the most recent NHS Atlas of Variation [21]. These levels of inappropriate variation
(i.e. unexplained by patient morbidity or preferences) are all the more striking given that
Fig 1. Practice achievement and 95% confidence intervals for blood pressure control in patients with hypertension.
https://doi.org/10.1371/journal.pone.0177949.g001
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several indicators were derived from QOF indicators and NICE guidelines [8]; whilst such ini-
tiatives might be necessary for quality improvement they are insufficient by themselves to
effectively target inappropriate variations.
One main study strength was the use of opt-out recruitment, whereby sampled practices
had to actively decline sharing of their data. This method can produce a larger sample whilst
avoiding some of the biases often associated with opt-in recruitment, and thus may be more
representative of typical general practices [31, 34].
Our study had several limitations. First, we considered quality of care from a single, techni-
cal perspective, i.e. achievement against selected clinical indicators. Other, important aspects
of care include interpersonal elements and practice accessibility, and variation has been dem-
onstrated here also (e.g. [13, 35]). Nevertheless, the indicators were the outcome of a rigorous
consensus process [8] and we are confident of their importance and relevance to both clini-
cians and patients.
Second, the sample was restricted to practices using a specific computerised patient record
system (SystmOne). Patient record systems are associated with small differences in achieve-
ment of incentivised targets [36]. We judged that this by itself was not a major limitation to
generalisability as regional coverage was high (over 80% of practices at the time of
recruitment).
Third, our study was limited to one geographical area, albeit one with practice characteris-
tics broadly similar to English averages. Moreover, our opt-out approach to practice data shar-
ing has helped ensure that the sample covers a typical range of practices and is likely to have
reduced selection bias.
Fourth, routinely collected electronic data offers an efficient but flawed means of gathering
large-scale information. Detailed checking of patient records was not possible and it was evi-
dent that coding errors were present. In particular, patient ethnicity was poorly recorded: 41%
of the patient population in the sampled practices were recorded as ‘British or mixed British’,
with a further 14% as ‘unknown’ or ‘ethnic category not stated’. This is a recognised problem
with medical records [37] and made analysis of the variable and interpretation of its impact
practically meaningless. The quality of research using ‘big data’ is highly dependent upon the
quality of data entered, and the extent to which this represents care delivered.
Fifth, the use of combined indicators can mask varying performance between individual
component indicators. Giving equal weighting to indicators can also be contentious [38].
However, there is no single agreed method of combining indicators and our methods were
similar to those utilised elsewhere [12, 15, 17, 21, 33].
Sixth, we utilised a rather crude measure of deprivation (practice-averaged IMD) that did
not consider deprivation at the individual patient level and is likely to have masked differences
in variation across practice populations. For reasons of patient confidentiality, we were unable
to utilise more precise measures of deprivation.
Given that we were assessing a range of process and outcome indicators concerning differ-
ent patient populations and clinical behaviours, we would naturally expect different patterns
of associations. Nevertheless, we did identify some shared associations, particularly around
age, and gender and comorbidity.
Men were generally more likely than women to achieve indicators which is consistent with
previous evidence that men tend to receive better care for cardiovascular disease and diabetes
[39]. Females, however, were more likely to achieve recommended blood pressure targets in
hypertension, and less likely to be the recipient of a risky prescribing combination.
Age had a more varied relationship with our indicators. Older individuals were more likely
to receive diabetes processes of care and achieve recommended blood pressure targets. A
potential explanation is that older patients with diabetes and hypertension may visit their
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practice more frequently and thus be exposed to more opportunities for the management of
long term conditions. By contrast, two indicators more closely related to prescribing behaviour
were less likely to be achieved in older patients. The oldest patients were less likely to receive
anticoagulation for stroke prevention in atrial fibrillation. Concerns about frailty and bleeding
risk may be relevant here, despite evidence of the benefits of this treatment for elderly patients
[40]. Older patients were also less likely to receive recommended treatment for secondary pre-
vention of MI. It may be that prescribing of the four different recommended medications
(angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker; aspirin or alterna-
tive antiplatelet; beta-blocker; and statin) is less straightforward than in those who are rela-
tively young with fewer comorbidities and contraindications.
Risky prescribing was more likely in patients aged 40–79 years. Short-term prescription of
an NSAID without gastro-protection, for example, may be considered less of a risk in younger,
otherwise healthy patients. Risky prescribing was also significantly less likely in patients with
more comorbidities (i.e. on at least three QOF registers). This result might be considered
counter-intuitive if more comorbidities typically means being prescribed more medications,
and thus at greater chance of exposure to risky prescription combinations [41]. However, a
plausible explanation may be offered for our findings. As suggested in relation to the diabetes
results, having more comorbidities—and thus the potential for hazardous medical combina-
tions—may alert health professionals to the risks associated with NSAID prescribing. A study
in primary care in Scotland similarly found that risky prescribing was less likely in patients
with increasing numbers of repeat medications (as an indication of overall morbidity) [42].
Having a higher number of comorbidities was positively associated with achievement of the
diabetes processes, diabetes control, and hypertension target indicators, together with reduced
risky prescribing. This finding is consistent with other evidence of a positive relationship
between the number of chronic conditions and quality of care [e.g. 43, 44]. The precise nature
of the comorbid conditions in question is likely to be an important factor in such a relation-
ship: there is a growing body of evidence to suggest that the presence of diabetes is associated
with better preventive treatment of cardiovascular disease [45]. It is perhaps surprising, there-
fore, to find an inverse relationship between comorbidity and achievement of blood pressure
targets in CKD.
Practice-level characteristics showed few associations with indicator achievement and
wider evidence for their importance is inconsistent. For example, a systematic review of the
impact of practice size upon quality of care suggested that larger practices were associated with
improved care, but the evidence was mixed [28]. No association was found between depriva-
tion (measured at the level of primary care organisations) and achievement of diabetes pro-
cesses or outcomes in the NHS Atlas of Variation [21]. Notably, we found no associations with
practice training status although earlier work has suggested an association with features of
good quality care [46].
We have conducted parallel, qualitative work exploring health professionals’ views about
the determinants of adherence to several of the indicators analysed here [47] shedding some
light on the present findings. Interviewees recognised the importance of clinical recommenda-
tions from the population perspective, but were also clear that rigid adherence may not be
desirable for individual patients (e.g. where someone was already prescribed multiple medica-
tions). Attention to the needs of individual patients was considered a general influence across
clinical conditions and featured prominently in interviews. The desire to meet these needs
(which may be perceived by the clinician rather than actual) was described as a strong driver
of prescribing practice, in deciding whether to adhere to recommended targets in diabetes,
and in considering whether to prescribe anticoagulation for stroke prevention in atrial fibrilla-
tion. Of course, 100% adherence would not be achievable, nor appropriate, but the beliefs of
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clinical staff may contribute to the observed differences between practices as well as those asso-
ciated with patient age, gender and comorbidity.
A further possible factor is the role played by organisational culture. Focusing upon the dia-
betes control indicator, a recent systematic review of qualitative studies [48] offers potential
explanations for the recognised between-practice variation. Several of the identified themes
concerned professional and organisational components, including resource constraints, defi-
cits in knowledge and skills and uncertainties about professional roles. Thus, higher-perform-
ing practices may be those with better structured management systems, access to specialist
teams, and shared awareness of guideline recommendations. Elsewhere, the degree of variation
observed is suggested to be related “predominantly to the ways in which services for people
with diabetes are organised” [21, p.105]. Our finding that practices with higher QOF perfor-
mance and those with better reported accessibility were more likely to achieve this indicator is
consistent with the view that organisation and culture play an important role in performance.
Our work has three messages for the improvement of care and further research. First, the
consistent, substantial variation between practices emphasises that this remains an important
issue, with variation existing at similar levels to that assessed almost two decades ago [13]. It is
concerning that the likelihood of receiving recommended care at different practices can vary
by such magnitude. There remains a need to better understand the reasons behind these differ-
ences and develop interventions to narrow the gap between the lowest and highest performers.
A small number of studies have examined variation at multiple levels, i.e. that occurring
between practices and that between practitioners within practices [42]. This has shown how
the role played by different types of variation differs by the outcomes under observation.
Unfortunately, this level of analysis was not possible in the current study as individual clini-
cians could not be identified.
Second, the modest but significant associations between achievement and specific patient
characteristics have implications for improvement strategies. Better performance on the diabe-
tes, hypertension and risky prescribing indicators was associated with comorbidity. Thus,
greater attention could be focused upon patients who are (relatively) healthier and conse-
quently less likely to attend the practice. We notably did find an association between practice
accessibility and achievement of the diabetes control indicator.
Third, the associations between patient and practice variables and indicator achievement
suggests the importance of clinical and organisational behaviours. Qualitative research has
shown that health professionals often believe that practice performance is heavily influenced
by local casemix or demographic variables [47]. Research such as our own can combat such
potentially erroneous perceptions. The potential importance of organisational culture is recog-
nised [35, 49]. Our recent qualitative work also recognised the importance of internal practice
norms and ways of working, e.g. shared understanding of professional roles and the delegation
of responsibilities for different tasks and management decisions [47]. Partly due to difficulty of
measurement, organisational culture or climate is often not considered but warrants further
investigation. Further work is needed to elucidate the reasons for practice-level variation and
to design and evaluate interventions targeting practice teams to encourage consistent delivery
of evidence-based clinical care.
Several interventions to promote guideline implementation (e.g. audit and feedback, educa-
tional outreach) have modest if variable effects [50, 51]. We are presently conducting a cluster
randomised controlled trial of an intervention to improve achievement of a subset of high
impact indicators by targeting identified barriers to change [52].
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